[DOI] [PubMed] [Google Scholar] 80.Klicek R., Kolenc D., Suran J., Drmic D., Brcic L., Aralica G., Sever M., Holjevac J., Radic B., Turudic T., et al
The catalytic activity of cIII depends on three redox-active subunits: cytochrome b (MT-CYB), the Rieske iron-sulfur [Fe2-S2] protein (UQCRFS1), and cytochrome c1 (CYC1) (Yang and Trumpower, 1986)
Identifying and correcting these imbalances enhances recovery and immune balance
2010 Mar;16(3):BR81-88
Cost should never be the primary factor in choosing a treatment approach, but accessibility matters
To conclude, for the suggested further BPC 157 therapy applications, the strength of evidence of its pleiotropic beneficial effects of therapy should be reviewed from the viewpoint of the possible neurotransmitter activity